GET THE APP

Cardiovascular Pharmacology: Open Access

Cardiovascular Pharmacology: Open Access
Open Access

ISSN: 2329-6607

44-1258650017

Abhijit Trailokya

Abhijit Trailokya
Abbott Healthcare Private Limited,
Mulund, Mumbai 400 080
India

Publications
  • Review Article
    Acenocoumarol in Thromboembolic Disorders
    Author(s): Abhijit TrailokyaAbhijit Trailokya

    Thromboembolic disorders are common worldwide, frequently a leading cause of death. Judicial use of Anticoagulant plays an important role in the prevention and treatment of Venous and arterial thromboembolic diseases like deep vein thrombosis, pulmonary embolism, Stroke prevention in valvular and Non-valvular heart disease, and Acute coronary syndrome. Vitamin K antagonists, e.g., acenocoumerol and warfarin are commonly used as oral anticoagulants worldwide. The clinical use of oral anticoagulants has come a long way since their discovery over 50 years ago and Acenocoumarol is a coumarin derivative with pharmacological features closer to an ideal oral anticoagulant. Acenocoumarol is a drug with over 50 years of clinical experience and has been the subject of numerous clinical studies Acenocoumarol is prescribed once every day orally, as the anticoagulant is applied in various thromboe.. Read More»
    DOI: 10.4172/2329-6607.1000157

    Abstract PDF

Relevant Topics

Top